Buprenorphine in the Treatment of Opioid Dependence

Home  >  Sitemap  

Sitemap

Home

Why should I take this course?

Qualifying for Office-based Buprenorphine Treatment

What is the scope of the problem?

What is the significance of the problem?

New role for physicians

What information does this course provide?

Educational Goals

Educational Objectives

  

  Before You Start

How to use the course

Course Sponsors and Development

About the AAAP

About Danya International

About CSAT

Authors and Acknowledgments

Accreditation

  

Course Modules

Module 1: Overview

Module 2:  About This Course

Module 3:  Recent Legislative Changes

Module 4:  Basic Opioid Pharmacology

Module 5:  Pharmacology of Buprenorphine

Module 6:  Effectiveness and Safety of Buprenorphine

Module 7:  Overview to Patient Assessment

Module 8:  Assessing Patient for Suitability

Module 9:  Clinical Management

Module 10:  Special Populations

Module 11:   Buprenorphine/Naloxone Dosing

Module 12:  Urine Testing

Module 13:  Patient Confidentiality

Case Studies

 
   

Additional Resources

Online Resources

Bibliography

back   top next

Site Map  |   HHS Privacy Statement  |  Contact Us  |  Danya Learning Center
Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment.
Last updated: September 20, 2002.